Primary Site >> Liver Cancer
Gene >> DLC1
| 1. | |||||||||||
| Journal: | Cancer Res. 1998 May 15;58(10):2196-9. | ||||||||||
| Title: | Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. | ||||||||||
| Author: | Yuan, B Z|Miller, M J|Keck, C L|Zimonjic, D B|Thorgeirsson, S S|Popescu, N C | ||||||||||
| PMID: | 9605766 | ||||||||||
| 2. | |||||||||||
| Journal: | Hum Mutat. 2000;15(2):156-65. | ||||||||||
| Title: | Sequence variants of DLC1 in colorectal and ovarian tumours. | ||||||||||
| Author: | Wilson, P J|McGlinn, E|Marsh, A|Evans, T|Arnold, J|Wright, K|Biden, K|Young, J|Wainwright, B|Wicking, C|Chenevix-Trench, G | ||||||||||
| PMID: | 10649492 | ||||||||||
| 3. | |||||||||||
| Journal: | Gene. 2002 Apr 17;288(1-2):119-27. | ||||||||||
| Title: | Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7). | ||||||||||
| Author: | Durkin, Marian E|Yuan, Bao-Zhu|Thorgeirsson, Snorri S|Popescu, Nicholas C | ||||||||||
| PMID: | 12034501 | ||||||||||
| 4. | |||||||||||
| Journal: | J Biol Chem. 2003 Mar 21;278(12):10824-30. | ||||||||||
| Title: | Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. | ||||||||||
| Author: | Ching, Yick-Pang|Wong, Chun-Ming|Chan, Shing-Fai|Leung, Thomas Ho-Yin|Ng, David Chi-Heng|Jin, Dong-Yan|Ng, Irene Oi-lin | ||||||||||
| PMID: | 12531887 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncogene. 2003 Jun 19;22(25):3943-51. | ||||||||||
| Title: | Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. | ||||||||||
| Author: | Kim, Tai Young|Jong, Hyun-Soon|Song, Sang-Hyun|Dimtchev, Alexandre|Jeong, Sook-Jung|Lee, Jung Weon|Kim, Tae-You|Kim, Noe Kyeong|Jung, Mira|Bang, Yung-Jue | ||||||||||
| PMID: | 12813468 | ||||||||||
| 6. | |||||||||||
| Journal: | Mutat Res. 2003 Jul 25;528(1-2):45-53. | ||||||||||
| Title: | Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. | ||||||||||
| Author: | Zheng, Siqun L|Mychaleckyj, Josyf C|Hawkins, Gregory A|Isaacs, Sarah D|Wiley, Kathy E|Turner, Aubrey|Chang, Bao-li|von Kap-Herr, Chris|Carpten, John D|Pettenati, Mark|Bleecker, Eugene R|Walsh, Patrick C|Trent, Jeffrey M|Meyers, Deborah A|Isaacs, William B | ||||||||||
| PMID: | 12873722 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res. 2005 Oct 1;65(19):8861-8. | ||||||||||
| Title: | Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. | ||||||||||
| Author: | Wong, Chun-Ming|Yam, Judy Wai-Ping|Ching, Yick-Pang|Yau, Tai-On|Leung, Thomas Ho-Yin|Jin, Dong-Yan|Ng, Irene Oi-Lin | ||||||||||
| PMID: | 16204057 | ||||||||||
| 8. | |||||||||||
| Journal: | J Biol Chem. 2006 Feb 24;281(8):4762-70. | ||||||||||
| Title: | Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells. | ||||||||||
| Author: | Hers, Ingeborg|Wherlock, Matthew|Homma, Yoshimi|Yagisawa, Hitoshi|Tavare, Jeremy M | ||||||||||
| PMID: | 16338927 | ||||||||||
| 9. | |||||||||||
| Journal: | Cancer Res. 2006 Sep 1;66(17):8367-72. | ||||||||||
| Title: | Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. | ||||||||||
| Author: | Yam, Judy Wai Ping|Ko, Frankie Chi Fat|Chan, Chung-Yiu|Jin, Dong-Yan|Ng, Irene Oi-Lin | ||||||||||
| PMID: | 16951145 | ||||||||||
| 10. | |||||||||||
| Journal: | Mod Pathol. 2006 Dec;19(12):1546-54. | ||||||||||
| Title: | Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. | ||||||||||
| Author: | Chan, Kathy Y-Y|Lai, Paul B-S|Squire, Jeremy A|Beheshti, Ben|Wong, Navy L-Y|Sy, Shirley M-H|Wong, Nathalie | ||||||||||
| PMID: | 16980951 | ||||||||||
| 11. | |||||||||||
| Journal: | Int J Oncol. 2006 Nov;29(5):1127-32. | ||||||||||
| Title: | Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. | ||||||||||
| Author: | Ullmannova, Veronika|Popescu, Nicholas C | ||||||||||
| PMID: | 17016643 | ||||||||||
| 12. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2007 May 22;104(21):9012-7. | ||||||||||
| Title: | Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. | ||||||||||
| Author: | Qian, Xiaolan|Li, Guorong|Asmussen, Holly K|Asnaghi, Laura|Vass, William C|Braverman, Richard|Yamada, Kenneth M|Popescu, Nicholas C|Papageorge, Alex G|Lowy, Douglas R | ||||||||||
| PMID: | 17517630 | ||||||||||
| 13. | |||||||||||
| Journal: | Int J Oncol. 2008 Jun;32(6):1285-91. | ||||||||||
| Title: | DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. | ||||||||||
| Author: | Zhou, Xiaoling|Zimonjic, Drazen B|Park, Sang-Won|Yang, Xu-Yu|Durkin, Marian E|Popescu, Nicholas C | ||||||||||
| PMID: | 18497990 | ||||||||||
| 14. | |||||||||||
| Journal: | PLoS One. 2008 Jul 23;3(7):e2779. | ||||||||||
| Title: | Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. | ||||||||||
| Author: | Wong, Carmen Chak-Lui|Wong, Chun-Ming|Ko, Frankie Chi-Fat|Chan, Lo-Kong|Ching, Yick-Pang|Yam, Judy Wai-Ping|Ng, Irene Oi-lin | ||||||||||
| PMID: | 18648664 | ||||||||||
| 15. | |||||||||||
| Journal: | Genes Dev. 2008 Jun 1;22(11):1439-44. | ||||||||||
| Title: | DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. | ||||||||||
| Author: | Xue, Wen|Krasnitz, Alexander|Lucito, Robert|Sordella, Raffaella|Vanaelst, Linda|Cordon-Cardo, Carlos|Singer, Stephan|Kuehnel, Florian|Wigler, Michael|Powers, Scott|Zender, Lars|Lowe, Scott W | ||||||||||
| PMID: | 18519636 | ||||||||||
| 16. | |||||||||||
| Journal: | PLoS One. 2009;4(5):e5572. | ||||||||||
| Title: | Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. | ||||||||||
| Author: | Chan, Lo-Kong|Ko, Frankie Chi Fat|Ng, Irene Oi-Lin|Yam, Judy Wai Ping | ||||||||||
| PMID: | 19440389 | ||||||||||
| 17. | |||||||||||
| Journal: | PLoS One. 2009 Aug 10;4(8):e6566. | ||||||||||
| Title: | Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis. | ||||||||||
| Author: | Yau, Tai On|Leung, Thomas Ho Yin|Lam, Sandra|Cheung, Oi Fung|Tung, Edmund Kwok Kwan|Khong, Pek Lan|Lam, Amy|Chung, Sookja|Ng, Irene Oi Lin | ||||||||||
| PMID: | 19668331 | ||||||||||
| 18. | |||||||||||
| Journal: | Cancer Epidemiol. 2009 Oct;33(3-4):265-70. | ||||||||||
| Title: | Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. | ||||||||||
| Author: | Dong, Xiaoqun|Zhou, Gangqiao|Zhai, Yun|Zhang, Hongxing|Yang, Hao|Zhi, Lianteng|Zhang, Xiumei|Chu, Jiayou|He, Fuchu | ||||||||||
| PMID: | 19766077 | ||||||||||
| 19. | |||||||||||
| Journal: | Liver Int. 2010 Jan;30(1):139-48. | ||||||||||
| Title: | Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma. | ||||||||||
| Author: | Ko, Frankie Chi Fat|Yeung, Yin-Shan|Wong, Chun-Ming|Chan, Lo-Kong|Poon, Ronnie Tung Ping|Ng, Irene Oi-Lin|Yam, Judy Wai Ping | ||||||||||
| PMID: | 19874489 | ||||||||||
| 20. | |||||||||||
| Journal: | Gastroenterology. 2010 Oct;139(4):1397-407. | ||||||||||
| Title: | Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis. | ||||||||||
| Author: | Ko, Frankie Chi Fat|Chan, Lo-Kong|Tung, Edmund Kwok-Kwan|Lowe, Scott W|Ng, Irene Oi-Lin|Yam, Judy Wai Ping | ||||||||||
| PMID: | 20600027 | ||||||||||
| 21. | |||||||||||
| Journal: | Gastroenterology. 2010 Oct;139(4):1093-6. | ||||||||||
| Title: | DLC1 and liver cancer: the Akt connection. | ||||||||||
| Author: | Wuestefeld, Torsten|Zender, Lars | ||||||||||
| PMID: | 20800109 | ||||||||||
| 22. | |||||||||||
| Journal: | Oncol Lett. 2011 Sep 1;2(5):763-768. | ||||||||||
| Title: | Deleted in liver cancer protein family in human malignancies (Review). | ||||||||||
| Author: | Lukasik, D|Wilczek, E|Wasiutynski, A|Gornicka, B | ||||||||||
| PMID: | 22866123 | ||||||||||
| 23. | |||||||||||
| Journal: | Int J Mol Sci. 2011;12(12):8489-501. | ||||||||||
| Title: | Pilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinoma. | ||||||||||
| Author: | Fan, Dong-Mei|Shi, Hui-Rong | ||||||||||
| PMID: | 22272086 | ||||||||||
| 24. | |||||||||||
| Journal: | PLoS One. 2011;6(9):e25547. | ||||||||||
| Title: | Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo. | ||||||||||
| Author: | Chan, Lo-Kong|Ko, Frankie Chi Fat|Sze, Karen Man-Fong|Ng, Irene Oi-Lin|Yam, Judy Wai Ping | ||||||||||
| PMID: | 21966542 | ||||||||||
| 25. | |||||||||||
| Journal: | Oncol Rep. 2011 Jun;25(6):1739-46. | ||||||||||
| Title: | Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth. | ||||||||||
| Author: | Chung, Goh Eun|Yoon, Jung-Hwan|Lee, Jeong-Hoon|Kim, Hwi Young|Myung, Sun Jung|Yu, Su Jong|Lee, Sung-Hee|Lee, Soo-Mi|Kim, Yoon Jun|Lee, Hyo-Suk | ||||||||||
| PMID: | 21455586 | ||||||||||
| 26. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2011 Jan 7;404(1):279-83. | ||||||||||
| Title: | The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B. | ||||||||||
| Author: | Luo, Hong-wei|Luo, Qiu-ping|Yuan, Ying|Zhu, Xiao-ying|Huang, Shi-feng|Peng, Zhi|Li, Chun-li|Huang, Zong-gan|Feng, Wen-li | ||||||||||
| PMID: | 21130076 | ||||||||||
| 27. | |||||||||||
| Journal: | J Hepatol. 2011 Dec;55(6):1400-8. | ||||||||||
| Title: | Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway. | ||||||||||
| Author: | Kudo, Yotaro|Tanaka, Yasuo|Tateishi, Keisuke|Yamamoto, Keisuke|Yamamoto, Shinzo|Mohri, Dai|Isomura, Yoshihiro|Seto, Motoko|Nakagawa, Hayato|Asaoka, Yoshinari|Tada, Motohisa|Ohta, Miki|Ijichi, Hideaki|Hirata, Yoshihiro|Otsuka, Motoyuki|Ikenoue, Tsuneo|Maed | ||||||||||
| PMID: | 21703185 | ||||||||||
| 28. | |||||||||||
| Journal: | Mod Pathol. 2012 Jan;25(1):14-25. | ||||||||||
| Title: | Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma. | ||||||||||
| Author: | Tripathi, Satyendra Chandra|Kaur, Jatinder|Matta, Ajay|Gao, Xin|Sun, Bin|Chauhan, Shyam Singh|Thakar, Alok|Shukla, Nootan Kumar|Duggal, Ritu|Choudhary, Ajoy Roy|DattaGupta, Siddhartha|Sharma, Mehar Chand|Ralhan, Ranju|Siu, K W Michael | ||||||||||
| PMID: | 22002576 | ||||||||||
| 29. | |||||||||||
| Journal: | Oncogene. 2012 Aug 30;31(35):3913-23. | ||||||||||
| Title: | The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1. | ||||||||||
| Author: | Muehlich, S|Hampl, V|Khalid, S|Singer, S|Frank, N|Breuhahn, K|Gudermann, T|Prywes, R | ||||||||||
| PMID: | 22139079 | ||||||||||
| 30. | |||||||||||
| Journal: | Gastroenterology. 2012 Apr;142(4):957-966.e12. | ||||||||||
| Title: | Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. | ||||||||||
| Author: | Roessler, Stephanie|Long, Ezhou Lori|Budhu, Anuradha|Chen, Yidong|Zhao, Xuelian|Ji, Junfang|Walker, Robert|Jia, Hu-Liang|Ye, Qing-Hai|Qin, Lun-Xiu|Tang, Zhao-You|He, Ping|Hunter, Kent W|Thorgeirsson, Snorri S|Meltzer, Paul S|Wang, Xin Wei | ||||||||||
| PMID: | 22202459 | ||||||||||
| 31. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2012 Apr 6;420(2):325-30. | ||||||||||
| Title: | Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. | ||||||||||
| Author: | Zhou, Xiaoling|Yang, Xu-Yu|Popescu, Nicholas C | ||||||||||
| PMID: | 22425986 | ||||||||||
| 32. | |||||||||||
| Journal: | Int J Oncol. 2012 Aug;41(2):393-406. | ||||||||||
| Title: | Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). | ||||||||||
| Author: | Zimonjic, Drazen B|Popescu, Nicholas C | ||||||||||
| PMID: | 22580498 | ||||||||||
| 33. | |||||||||||
| Journal: | J Biol Chem. 2012 Jul 27;287(31):26104-14. | ||||||||||
| Title: | Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode. | ||||||||||
| Author: | Chen, Lihong|Liu, Changdong|Ko, Frankie Chi Fat|Xu, Naining|Ng, Irene Oi-Lin|Yam, Judy Wai Ping|Zhu, Guang | ||||||||||
| PMID: | 22645138 | ||||||||||
| 34. | |||||||||||
| Journal: | PLoS One. 2012;7(7):e40302. | ||||||||||
| Title: | The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer. | ||||||||||
| Author: | Sabbir, Mohammad Golam|Prieditis, Heather|Ravinsky, Esther|Mowat, Michael R A | ||||||||||
| PMID: | 22792269 | ||||||||||
| 35. | |||||||||||
| Journal: | Nat Commun. 2013;4:1618. | ||||||||||
| Title: | PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis. | ||||||||||
| Author: | Ko, Frankie Chi Fat|Chan, Lo-Kong|Sze, Karen Man-Fong|Yeung, Yin-Shan|Tse, Edith Yuk-Ting|Lu, Ping|Yu, Ming-Hua|Ng, Irene Oi-Lin|Yam, Judy Wai Ping | ||||||||||
| PMID: | 23511482 | ||||||||||
| 36. | |||||||||||
| Journal: | PLoS One. 2013 Jun 27;8(6):e68226. | ||||||||||
| Title: | EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers. | ||||||||||
| Author: | Au, Sandy Leung-Kuen|Wong, Carmen Chak-Lui|Lee, Joyce Man-Fong|Wong, Chun-Ming|Ng, Irene Oi-Lin | ||||||||||
| PMID: | 23826380 | ||||||||||
| 37. | |||||||||||
| Journal: | EMBO Mol Med. 2013 Sep;5(9):1367-82. | ||||||||||
| Title: | Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence. | ||||||||||
| Author: | Hampl, Veronika|Martin, Claudia|Aigner, Achim|Hoebel, Sabrina|Singer, Stephan|Frank, Natalie|Sarikas, Antonio|Ebert, Oliver|Prywes, Ron|Gudermann, Thomas|Muehlich, Susanne | ||||||||||
| PMID: | 23853104 | ||||||||||
| 38. | |||||||||||
| Journal: | Oncol Lett. 2014 Aug;8(2):785-788. | ||||||||||
| Title: | Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections. | ||||||||||
| Author: | Wolosz, Dominika|Walczak, Agnieszka|Wilczynski, Grzegorz M|Szparecki, Grzegorz|Wilczek, Ewa|Gornicka, Barbara | ||||||||||
| PMID: | 25013499 | ||||||||||
| 39. | |||||||||||
| Journal: | J Biol Chem. 2014 Mar 7;289(10):6839-49. | ||||||||||
| Title: | Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger. | ||||||||||
| Author: | Jaiswal, Mamta|Dvorsky, Radovan|Amin, Ehsan|Risse, Sarah L|Fansa, Eyad K|Zhang, Si-Cai|Taha, Mohamed S|Gauhar, Aziz R|Nakhaei-Rad, Saeideh|Kordes, Claus|Koessmeier, Katja T|Cirstea, Ion C|Olayioye, Monilola A|Haussinger, Dieter|Ahmadian, Mohammad R | ||||||||||
| PMID: | 24443565 | ||||||||||
| 40. | |||||||||||
| Journal: | Int J Oncol. 2015 Feb;46(2):782-90. | ||||||||||
| Title: | Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma. | ||||||||||
| Author: | Fang, Qin-Liang|Yin, Yi-Rui|Xie, Cheng-Rong|Zhang, Sheng|Zhao, Wen-Xiu|Pan, Chao|Wang, Xiao-Min|Yin, Zhen-Yu | ||||||||||
| PMID: | 25420499 | ||||||||||
| 41. | |||||||||||
| Journal: | Mol Med Rep. 2015 Sep;12(3):4203-4209. | ||||||||||
| Title: | Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma. | ||||||||||
| Author: | Xie, Cheng-Rong|Sun, Hong-Guang|Sun, Yu|Zhao, Wen-Xiu|Zhang, Sheng|Wang, Xiao-Min|Yin, Zhen-Yu | ||||||||||
| PMID: | 26095787 | ||||||||||
| 42. | |||||||||||
| Journal: | Diagn Pathol. 2016 Feb 4;11:19. | ||||||||||
| Title: | DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer. | ||||||||||
| Author: | Song, L J|Liu, Q|Meng, X R|Li, Sh L|Wang, L X|Fan, Q X|Xuan, X Y | ||||||||||
| PMID: | 26846339 | ||||||||||
| 43. | |||||||||||
| Journal: | Mol Med Rep. 2016 May;13(5):4095-100. | ||||||||||
| Title: | rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosis. | ||||||||||
| Author: | Ding, Xia|Gao, Sumei|Yang, Qifeng | ||||||||||
| PMID: | 26986853 | ||||||||||
| 44. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 19;7(29):45144-45157. | ||||||||||
| Title: | DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers. | ||||||||||
| Author: | Wang, Dunrui|Qian, Xiaolan|Rajaram, Megha|Durkin, Marian E|Lowy, Douglas R | ||||||||||
| PMID: | 27174913 | ||||||||||
| 45. | |||||||||||
| Journal: | Oncol Lett. 2016 Aug;12(2):1591-1596. | ||||||||||
| Title: | Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications. | ||||||||||
| Author: | Yang, Xuyu|Zhou, Xiaoling|Tone, Paul|Durkin, Marian E|Popescu, Nicholas C | ||||||||||
| PMID: | 27446476 | ||||||||||
| 46. | |||||||||||
| Journal: | Oncotarget. 2016 Dec 6;7(49):81255-81267. | ||||||||||
| Title: | Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma. | ||||||||||
| Author: | Zhang, Cheng|Li, Jinyun|Huang, Tao|Duan, Shiwei|Dai, Dongjun|Jiang, Danjie|Sui, Xinbing|Li, Da|Chen, Yidan|Ding, Fei|Huang, Changxin|Chen, Gongying|Wang, Kaifeng | ||||||||||
| PMID: | 27835605 | ||||||||||
| 47. | |||||||||||
| Journal: | PLoS One. 2017 Mar 30;12(3):e0174761. | ||||||||||
| Title: | Regulation of white and brown adipocyte differentiation by RhoGAP DLC1. | ||||||||||
| Author: | Sim, Choon Kiat|Kim, Sun-Yee|Brunmeir, Reinhard|Zhang, Qiongyi|Li, Hongyu|Dharmasegaran, Dharmini|Leong, Carol|Lim, Ying Yan|Han, Weiping|Xu, Feng | ||||||||||
| PMID: | 28358928 | ||||||||||
| 48. | |||||||||||
| Journal: | Oncotarget. 2017 Jul 15;8(33):55422-55434. | ||||||||||
| Title: | Resveratrol inhibits age-dependent spontaneous tumorigenesis by SIRT1-mediated post-translational modulations in the annual fish Nothobranchius guentheri. | ||||||||||
| Author: | Liu, Tingting|Ma, Long|Zheng, Zhaodi|Li, Fenglin|Liu, Shan|Xie, Yingbo|Li, Guorong | ||||||||||
| PMID: | 28903430 | ||||||||||
| 49. | |||||||||||
| Journal: | Am J Transl Res. 2017 Sep 15;9(9):3904-3917. eCollection 2017. | ||||||||||
| Title: | Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics. | ||||||||||
| Author: | Zhang, Yu|Dang, Yi-Wu|Wang, Xiao|Yang, Xia|Zhang, Rui|Lv, Zi-Li|Chen, Gang | ||||||||||
| PMID: | 28979669 | ||||||||||
| 50. | |||||||||||
| Journal: | Nat Commun. 2017 Oct 30;8(1):1185. | ||||||||||
| Title: | Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration. | ||||||||||
| Author: | Liu, Jessica Aijia|Rao, Yanxia|Cheung, May Pui Lai|Hui, Man-Ning|Wu, Ming-Hoi|Chan, Lo-Kong|Ng, Irene Oi-Lin|Niu, Ben|Cheah, Kathryn S E|Sharma, Rakesh|Hodgson, Louis|Cheung, Martin | ||||||||||
| PMID: | 29084958 | ||||||||||
| 51. | |||||||||||
| Journal: | Lab Invest. 2018 Aug;98(8):1014-1024. | ||||||||||
| Title: | The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. | ||||||||||
| Author: | Wu, Hui-Ta|Xie, Cheng-Rong|Lv, Jie|Qi, He-Qiang|Wang, Fei|Zhang, Sheng|Fang, Qin-Liang|Wang, Fu-Qiang|Lu, Yu-Yan|Yin, Zhen-Yu | ||||||||||
| PMID: | 29785050 | ||||||||||
| 52. | |||||||||||
| Journal: | Int J Cancer. 2018 Oct 5. | ||||||||||
| Title: | PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases. | ||||||||||
| Author: | Yang, Jie|Trepo, Eric|Nahon, Pierre|Cao, Qian|Moreno, Christophe|Letouze, Eric|Imbeaud, Sandrine|Gustot, Thierry|Deviere, Jacques|Debette, Stephanie|Amouyel, Philippe|Bioulac-Sage, Paulette|Calderaro, Julien|Ganne-Carrie, Nathalie|Laurent, Alexis|Blanc, J | ||||||||||
| PMID: | 30289982 | ||||||||||